Meeting
2023 ASCO Genitourinary Cancers Symposium
Cabozantinib in the elderly with metastatic renal cell carcinoma undergoing geriatric G8 screening test: A prospective multicenter observational study (ZEBRA/MEET-URO 9).
Authors
Umberto Basso
Oncology Unit 1, Department of Oncolgoy, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy
Umberto Basso , Sebastiano Buti , Elena Verzoni , Mariella Sorarù , Marilena Di Napoli , Lucia Fratino , Daniele Santini , Francesco Grillone , Vincenzo Emanuele Emanuele Chiuri , Claudia Carella , Francesco Atzori , Giandomenico Roviello , Donata Sartori , Marco Maruzzo , Francesco Pierantoni , Melissa Bersanelli , Melissa Ballestrin , Chiara De Toni , Alvise Mattana , Vittorina Zagonel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 647)
DOI
10.1200/JCO.2023.41.6_suppl.647
Abstract #
647
Poster Bd #
F17
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world efficacy and toxicity of ipilimumab and nivolumab as first line treatment of metastatic renal cell carcinoma (mRCC) in a subpopulation of elderly and poor performance status patients.
First Author: Ana-Alicia Beltran-Bless
Poster
2023 ASCO Annual Meeting
Regorafenib in older adults with metastatic colorectal cancer: A multi-center, single arm phase II trial.
First Author: Nabeel Badri
Poster
2023 ASCO Genitourinary Cancers Symposium
Drug-drug interactions (DDIs) in elderly patients with metastatic renal cell carcinoma (mRCC) treated with cabozantinib within the multicenter prospective trial ZEBRA/Meet-URO 9.
First Author: Alvise Mattana
Poster
2023 ASCO Genitourinary Cancers Symposium
Real-time evidence synthesis for first line (1L) treatment of metastatic renal cell carcinoma (mRCC): A living, interactive systematic review and Bayesian network meta-analysis.
First Author: Syed Arsalan Ahmed Naqvi